DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "The Corporate Reputation of Pharma Industry - The Patient Perspective in 2015 - Nordic Edition" report to their offering.
This report is based on the findings of a November 2015-January 2016 survey exploring the views of 147 Nordic patient groups in 2015, focusing on differing medical specialties. The report provides feedback on the corporate reputation of the Nordic pharma industry during 2015, as well as the performance of 20 pharma companies for six key indicators that influence corporate reputation. Results are compared with those of the previous year.
The report also offers, as case studies, survey responses from two companies: Leo Pharma and Lundbeck, which explain what they are doing on the subject of global patient centricity, and comments about its relationships with patient groups.
Profiles Of the 13 Companies, According To the Patient Groups in the Nordic Region Familiar with These Companies, or Have Worked With Them
Each profile contains
Company Background Information
- Annual revenue (latest-available year), comprising amount in currency, as quoted by the profiled company itself. Increase in revenue over the previous year or decrease in revenue.
- The profiled company's main treatment subject areas (and areas of R&D).
- A mission statement from the profiled company.
Companies Mentioned
- AbbVie
- Actavis
- Amgen
- AstraZeneca
- Bayer
- Boehringer Ingelheim
- Bristol-Myers Squibb
- GSK
- Janssen
- Leo Pharma
- Lilly
- Lundbeck
- Merck & Co
- Novartis
- Novo Nordisk
- Pfizer
- Roche
- Sandoz
- Sanofi
- Takeda
For more information about this report visit http://www.researchandmarkets.com/research/tvvxn9/the_corporate
